Detail of the clinical trial

Title of the trial A multicenter, randomized, double-blind, placebo-controlled study of the efficacy of natalizumab on reducing disability progression in subjects with secondary progressive multiple sclerosis
EudraCT number 2010-021978-11
Protocol number 101MS326
Sponsor Biogen Idec Ltd., UK
Indications Neurology
Diagnosis multiple sclerosis
Population in clinical trial
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 4.11.2011
Date of approval by EC 2.12.2011
Date of initiation CT in ČR 5.4.2012
Date of ending CT in ČR 4.11.2015 a 22.6.2016
Notice
Sites FN Hradec Králové, Neurologická klinika
FN Olomouc, Neurologická klinika
VFN Praha , RS Centrum, Neurolgická klinika, Praha 2
Pardubická krajská nemocnice a.s., MS centrum - neurologická klinika, Pardubice
FN Královské Vinohrady Praha , Neurologická klinika
FN u Sv. Anny v Brně, Brno

‹‹ Back to list